Medpace Holdings, Inc. to Report Third Quarter 2022 Financial Results on October 24, 2022

Rhea-AI Summary

Medpace Holdings, Inc. (Nasdaq: MEDP) will release its third quarter 2022 financial results after market close on October 24, 2022. A conference call will follow on October 25, 2022, at 9:00 a.m. ET to discuss these results. Interested parties can register here. A supplemental slide presentation will be available in the 'Investors' section of their website.

Positive

• Expected conference call indicates transparency and investor engagement.

Negative

• None.

CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2022 financial results after the market close on Monday, October 24, 2022. The Company will host a conference call the following morning, Tuesday, October 25, 2022, at 9:00 a.m. ET to discuss these results.

To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call.

To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,800 people across 41 countries as of June 30, 2022.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220927005951/en/

Investor Contact:

Lauren Morris

513.579.9911 x11994

l.morris@medpace.com

Media Contact:

Julie Hopkins

513.579.9911 x12627

j.hopkins@medpace.com

Source: Medpace Holdings, Inc.

FAQ

When will Medpace report its Q3 2022 financial results?

Medpace will report its Q3 2022 financial results after the market close on October 24, 2022.

What time is the Medpace conference call for Q3 2022 results?

The conference call will be held on October 25, 2022, at 9:00 a.m. ET.

How can I participate in the Medpace Q3 2022 conference call?

You can participate by registering in advance through the link provided in the press release.

Where can I find the replay of Medpace's Q3 2022 conference call?

The replay will be available on Medpace's Investor Relations website approximately one hour after the call.